These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15066748)

  • 1. Detection of extended-spectrum beta-lactamases in a Singapore routine clinical microbiology laboratory.
    Chiew YF
    J Hosp Infect; 2004 Apr; 56(4):328-9. PubMed ID: 15066748
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.
    Coudron PE
    J Clin Microbiol; 2005 Aug; 43(8):4163-7. PubMed ID: 16081966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of extended-spectrum beta-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method.
    Sorlózano A; Gutiérrez J; Palanca M; Soto MJ; Piédrola G
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):131-4. PubMed ID: 15474323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
    Ekşi F; Ozer G; Balci I
    Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.
    Pitout JD; Hossain A; Hanson ND
    J Clin Microbiol; 2004 Dec; 42(12):5715-21. PubMed ID: 15583304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh.
    Rahman MM; Haq JA; Hossain MA; Sultana R; Islam F; Islam AH
    Int J Antimicrob Agents; 2004 Nov; 24(5):508-10. PubMed ID: 15519486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of a rapid detection method for broad-spectrum beta-lactamases using a chromogenic cephalosporin].
    Yagüe A; Rodríguez JC; Sandvang D; Ruiz M; Royo G
    Rev Esp Quimioter; 2006 Jun; 19(2):185-6. PubMed ID: 16964336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods.
    Nyberg SD; Meurman O; Jalava J; Rantakokko-Jalava K
    Scand J Infect Dis; 2008; 40(5):355-62. PubMed ID: 17934979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
    Bell JM; Chitsaz M; Turnidge JD; Barton M; Walters LJ; Jones RN
    J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test.
    Shahid M; Malik A; Agrawal M; Singhal S
    J Antimicrob Chemother; 2004 Sep; 54(3):684-7. PubMed ID: 15294886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
    Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
    J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH
    Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.
    Pfaller MA; Segreti J
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S153-63. PubMed ID: 16544266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.